News, perspectives, and updates from Mentice

MENTICE GROWTH TRAJECTORY CONTINUES IN Q2 2026

SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2026 (APR – JUN)

Mentice to Present Q2 2026 Interim Report via Webcast

Mentice AB (STO: MNTC) invites investors, analysts and media to a webcast presentation of its Interim Report for the second quarter of 2026 on Thursda

Correction: Missing MAR label in earlier Press Release - Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company within Interventional Cardiology

Mentice (publ) issues a correction to the Press Release published on June 29th at 18:00. The correction concerns that the Press Release did not includ

Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease

Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided therapies, today announced the receipt of two orders in total

Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning

Gothenburg, Sweden – June 2026 – Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today a

Communique from annual general meeting in Mentice AB

An annual general meeting was held in Mentice AB on 26 May 2026. Below follows a summary of the resolutions made at the meeting.

INTERIM REPORT JAN–MAR 2026

CONTINUED MOMENTUM AND STRONG ORGANIC GROWTH

Annual shareholders’ meeting in Mentice AB

The shareholders in Mentice AB, reg. no. 556556-4241, (the “Company”), are hereby invited to attend the annual shareholders’ meeting to be held on 26

Mentice AB Publishes Annual and Sustainability Report for 2025

Mentice AB (publ), Gothenburg – a globally recognized leader in simulation solutions for image-guided therapies, today published its Annual Report and

Mentice to Present Q1 2026 Interim Report via Webcast

Mentice AB (STO: MNTC) announces that the company will present its Q1 2026 Interim Report for the period January–March via a webcast conference call o

In Conversation with Prof. Dr. Jan De Pooter: A Physician’s Perspective on Electrophysiology and Simulation-Based Training.

A Journey Shaped by Curiosity and Collaboration

Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group

Mentice AB (publ), Gothenburg, Sweden – Mentice today announced the appointment of Rick van Veen as Chief Financial Officer, effective July 1, 2026. R

Communique from extraordinary shareholders’ meeting in Mentice AB

An extraordinary shareholders’ meeting was held in Mentice AB (“the Company”) on February 26, 2026. Below follows a summary of the resolutions made at

Mentice publishes the company’s year-end report for the period January–December 2025

STRONG ORGANIC GROWTH AND RESULT IMPROVEMENT DESPITE CURRENCY HEADWINDS

Mentice to Present the Company's Year-End Q4 Report 2025 via Webcast

Mentice AB (STO: MNTC) announces that the company will present its Year-End Q4-2025 interim report for the period October – December via a webcast con